| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Institute for Drug Discovery Research,*
Yamanouchi Pharmaceutical Co., Ltd., and the Institute of Basic Medical
Sciences,
University of Tsukuba, Tsukuba,
Ibaraki, Japan
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Matrix metalloproteinases (MMPs) are the most commonly observed ECM-degrading metal-dependent proteinases in atherogenic lesions.6-8,12-16 To date, at least 14 enzymes have been identified in humans. MMPs serve as key enzymes for the homeostasis of ECM in the physiological state.17 However, once their activities are abnormally exerted, they are known to cause various kinds of pathological events other than atherosclerosis, such as tumor metastasis,18,19 osteoarthritis, and rheumatoid arthritis.20,21
MMP-12 (macrophage elastase) was first identified as an elastolytic metalloproteinase secreted by inflammatory macrophages.22 Mouse and human MMP-12 cDNAs were both cloned from a macrophage cDNA library and found to share 64% homology at the amino acid level.23,24 Besides elastase activity, MMP-12 shows broad substrate specificity on ECM proteins such as fibronectin, laminin, vitronectin, type IV collagen, and heparan sulfate while having no proteolytic activity on type I collagen.25 Accordingly, MMP-12 not only digests elastin but also degrades the basement membrane, which allows macrophages to penetrate into injured tissue during inflammation.26
Although there are substantial numbers of reports on the localization of several MMPs in atherosclerotic lesions, little is known about the roles of MMP-12 in the pathogenesis of atherosclerosis. In this study, using immunohistochemical and biochemical methods, the expression of MMP-12 and its roles in atherosclerosis were examined in the aortas of rabbits fed a cholesterol-containing diet. The results present new evidence that MMP-12 plays a pivotal role in the development of atherosclerosis.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Male Japan white rabbits weighing 2.0 to 2.5 kg (10 weeks old initially) were fed a 1% cholesterol-containing diet for 16 weeks, as described previously.27 Age-matched control rabbits were fed a standard laboratory chow. Serum cholesterol levels were measured at the beginning and end of 16 weeks of the diet using Cholesterol E-test Wako (Wako Pure Chemical Industries, Osaka, Japan). After sacrifice, the blood was washed out of the carcass with phosphate-buffered saline, and the descending thoracic aorta was removed to use for total RNA preparation with ISOGEN (Nippongene, Toyama, Japan), Western blot analysis, and MFC isolation. Three rabbits from each group were used for Northern blot and Western blot analysis. Each sample was tested at least three times for each analysis. For immunohistochemistry, the aorta was fixed by perfusion of periodate-lysine-paraformaldehyde (PLP), removed en bloc, and immersed in the PLP fixative for 4 hours. The aorta was opened longitudinally, and samples of the descending thoracic aorta were embedded in paraffin for immunohistochemical studies. The sections were also stained with hematoxylin and eosin and van Gieson's elastin.
Catalytic Domain of Rabbit MMP-12 (MMP-12cat) Expressed in Escherichia coli
An E. coli expression plasmid for the catalytic domain of rabbit MMP-12 (MMP-12cat) was obtained as follows. Two oligonucleotides, 5'- CCCCCATGGCTAGCTTCAAAACCATGCCAGGGAG-3' (forward primer) and 5'- GGGGGATCCCTATGGCATGGGTTGATGCTGCTGCT-3' (reverse primer), were synthesized to encode the protein from Phe95 to Pro267, which is the catalytic domain of rabbit MMP-12. Using full-length cDNA of rabbit MMP-12 cloned from a rabbit osteoclast cDNA library (GenBank accession number AB006779, M. Kobori, manuscript in preparation), the polymerase chain reaction was carried out with the oligonucleotide primers, and the reaction product was ligated into the NcoI-BamHI site of an E. coli expression plasmid, pET-3d (Novagen, Madison, WI). E. coli strain BL21 (DE3) pLysS (Novagen) was transformed with the MMP-12cat expression plasmid, and MMP-12cat-containing E. coli inclusion bodies were refolded as described previously.28 The refolded MMP-12cat was loaded onto a heparin-Sepharose (Pharmacia LKB, Uppsala, Sweden) column, eluted with buffer A (50 mmol/L Tris/HCl, pH 7.5, 5 mmol/L CaCl2, 0.05 mmol/L ZnCl2, 0.05% Brij-35) containing 0.75 mol/L NaCl and then dialyzed against buffer A. The protein concentration was assessed with a protein assay kit (BioRad, Richmond, CA) according to the manufacturer's recommendations. Amino-terminal amino acid sequencing analysis was performed using protein sequencer model 473 (Perkin Elmer, Norwalk, CT).
Antibodies to Rabbit MMPs
Recombinant rabbit MMP-1, -3, and -9 were obtained as described previously.28 Mouse polyclonal antibody (Ab) against rabbit MMP-12 was raised using MMP-12cat as an antigen. For affinity purification, 500 µl of the immunized mouse serum was affinity absorbed to a 1-ml Sepharose 4B (Pharmacia) column coupled with 2 mg of MMP-12cat and eluted with 5 ml of 50 mmol/L glycine/HCl (pH 2.7). Specificity to other MMPs was eliminated from the affinity-purified anti-MMP-12 polyclonal Ab by continuous passage through Sepharose 4B columns coupled with rabbit MMP-1, -3, or -9, respectively and the unbound solution (25 ml) was used as the specific anti-rabbit MMP-12 polyclonal Ab. A mouse monoclonal anti-rabbit MMP-3 Ab, MP1807, was obtained using the recombinant precursor form of MMP-3 (pro-MMP-3) as an immunizing antigen. A mouse monoclonal anti-human MMP-2 Ab (Fuji Chemical Industries, Toyama, Japan) was used to detect rabbit MMP-2.29
Isolation of Aortic Cells and MFCs
For the isolation of aortic cells from whole aortas, thoracic aortas were cut into small pieces and then digested with an enzyme mixture containing 450 U/ml collagenase (Worthington Biochemical Co., Freehold, NJ), 4.7 U/ml elastase (Elastin Products Co., Owensville, MO), 1 mg/ml soybean trypsin inhibitor (Wako Pure Chemical Industries) and 2 mmol/L CaCl2 in Hanks' balanced salt solution (Gibco-BRL, Gaithersburg, MD) for 1 hour. The dissociated cells were filtered with a nylon membrane and suspended at 5.0 x 105 cells/ml in a serum-free medium, Media I (Immuno-Biologic Laboratories, Gunma, Japan). After 5 days of incubation, Western blot analysis28 using anti-MMP-12 polyclonal Ab was performed on conditioned medium. Purification of MFCs was performed according to the method described by Galis et al.12 Purified MFCs were suspended at 2.0 x 105 cells/ml in Media I, and Western blot analysis was performed on 12 µl of the conditioned medium collected after 3 days of culture. For identification of the MFCs, 2.5 x 103 cells were smeared on glass slides, fixed with 100% ethanol, and stained with a specific antibody to rabbit macrophages, RAM-11.30
Transient Expression of Rabbit MMPs in COS-7 Cells
For constructing mammalian cell expression plasmids for rabbit MMP-2, -3, and -12, each full-length cDNA was inserted into expression vector pEF-BOS-dhfr, and transient expression of the MMPs in COS-7 cells (CRL-1651, American Type Culture Collection (ATCC), Rockville, MD) was performed as described previously.28 Also, the full-length cDNA fragments of rabbit MMP-1 and -9 were used as probe DNAs for Northern blot analysis.29
Immunohistochemistry
Five-micron paraffin-embedded sections were prepared and mounted on glass slides. Serial sections were deparaffinized with xylene and a graded series of ethanol. Endogenous peroxidase activity was blocked by immersing the slides in 0.3% H2O2 for 10 minutes at room temperature. After blocking with 10% rabbit serum for 30 minutes at room temperature, each section was incubated overnight at 4°C with purified anti-rabbit MMP-12 polyclonal Ab diluted 1:50 or 1:500 in PBS containing 1% bovine serum albumin, anti-rabbit macrophage monoclonal (M)Ab, RAM-11, diluted 1:12,000, and anti- muscle actin MAb, HHF-35 (Enzo Biochemicals, Farmingdale, NY), diluted 1:100. The immunoreactivity was detected by the HISTOFINE SAB-PO(M) kit (Nichirei Co., Tokyo, Japan) following the manufacturer's instructions. Briefly, the slides were incubated with species-appropriate biotinylated secondary antibodies for 30 minutes, followed by peroxidase-conjugated streptavidin for 30 minutes at room temperature. The reaction was visualized with 3-amino-9-ethyl-carbazole (Dako Japan Co., Kyoto, Japan). The sections were counterstained with hematoxylin. Omission of primary antibodies and staining with type- and class-matched irrelevant immunoglobulin served as negative controls.
Double immunostaining was carried out for the identification of the cells producing MMP-12. Anti-rabbit MMP-12 polyclonal Ab was used for first primary Ab. After the first immunostaining procedure described above, the sections were rinsed with 0.1 mol/L glycine/HCl buffer (pH 2.2) for 1 hour to remove immunocomplexes and were incubated overnight at 4°C with the second primary Ab, RAM-11. Thereafter, the slides were incubated with species-appropriate biotinylated secondary antibodies for 30 minutes, followed by alkaline-phosphatase-conjugated streptavidin (Nichirei) for 30 minutes at room temperature. The reaction of the second primary Ab was visualized with fast blue (Nichirei).
Degradation of ECM Proteins by MMP-12cat
Type I, III, and V collagens from human placenta were purchased from Sigma Chemical Co. (St. Louis, MO), type II collagen of calf joints was purchased from Yagai Research Center (Yamagata, Japan), and type IV collagen of Engelbreth-Holm-Swarm mouse tumor was from Becton Dickinson (San Jose, CA). Purification of human plasma fibronectin and the proteolytic activity of MMP-12cat on the ECM proteins were performed as described previously.24 Briefly, 6 µg/ml MMP-12cat was incubated with 0.2 µg/ml type I, type II, type III, type IV, or type V collagens at 25°C for 25 hours or with 0.2 µg/ml fibronectin at 37°C for 25 hours. The reaction products were analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions and silver stained.
Effect of AcLDL on the Expression of MMP-12 from Macrophages
Human cell lines U937 (ATCC CRL-1593) and THP-1 (ATCC TIB-202), both of which have the ability to differentiate into macrophages, were cultured in RPMI-1640 (Gibco) supplemented with 10% fetal bovine serum (Gibco). For induction of macrophages, 1 x 107 U937 cells or 5 x 106 THP-1 cells were incubated in the medium containing 100 ng/ml phorbol 12-myristate 13-acetate (PMA) in 15-cm dishes. After 3 days of stimulation with PMA, the adherent cells were maintained in the same medium without PMA for an additional 3 days and used as a source of macrophages. To obtain acetylated low-density lipoprotein (AcLDL), bovine LDL (d = 1.02 to 1.06) (Yagai Research Center) was used according to the method described previously.31 The differentiated U937 and THP-1 cells were incubated in RPMI-1640 with or without 35 µg of protein/ml of AcLDL or 50 ng/ml human granulocyte macrophage-colony stimulating factor (GM-CSF) (PeproTech, London, UK) for 24 hours, and mRNA was isolated using ISOGEN and Oligotex-dt30 (Takara, Kyoto, Japan) to blot on a nylon membrane by 2 µg each. Human MMP-12-cDNA24 for use as a probe DNA was obtained by a polymerase chain reaction using human adult lung cDNA (Clontech, Palo Alto, CA) as template DNA. The amounts of mRNA expression were quantified with a bio-imaging analyzer, BAS2000 (Fuji Photo Film Co., Tokyo, Japan).
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Northern Blot Analysis of Rabbit Aorta
As shown in Figure 1
, MMP-12 was
present in the whole aorta with raised intima from cholesterol-fed
rabbits (Figure 1a
, lane 1). A much stronger signal for MMP-12 was
present in the atherosclerotic intimas (Figure 1b
, lanes 2 and 3) than
in the whole aorta with raised intima (Figure 1b
, lane 1), whereas no
MMP-12 signal was found in the aortas of normal rabbits (Figure 1, a and b
, lanes 4 and 5). MMP-1, -3, and -9 were also present only in the
cholesterol-fed rabbits (Figure 1, c, e, and f)
; on the other hand,
MMP-2 was detected in the aortas of both normal and cholesterol-fed
rabbits (Figure 1d)
.
|
To evaluate the protein expression of MMP-12 and its existing form
(Figure 2)
, Western blot analysis was
carried out on the conditioned medium of dissociated cells from the
whole aortas. As shown in Figure 3
,
MMP-12 was produced by the cells from a whole aorta with a raised
intima (lane 2) at a molecular weight of 45 kd, whereas the cells from
a lesion-negative whole aorta of a cholesterol-fed rabbit (lane 1) had
no such ability. Secretion of MMP-12 was also undetectable for the
cells from the whole aorta of a normal rabbit (lane 3). In comparison
with COS-7-expressed MMP-12 with (lane 5) or without (lane 4) previous
treatment with trypsin, the size of 45 kd detected in lane 2
corresponded to the activated form of MMP-12 (active MMP-12). On the
other hand, Western blot analysis for MMP-3 in the same sample revealed
that MMP-3 totally kept its latency (data not shown), indicating that
MMP-12 in lane 2 was not artificially activated during the extraction
procedure.
|
|
, lane 7). This demonstrated that, in the aorta of cholesterol-fed
rabbits, MFCs have the ability to generate MMP-12, which is readily
activated after its secretion. Immunohistochemistry
The atherosclerotic lesion in the thoracic aorta contained
RAM-11-positive round or foamy cells (MFCs) and HHF-35-positive cells
surrounded by various amounts of connective tissue matrix (Figure 4, a–c)
. In raised lesions,
RAM-11-positive MFCs tended to cluster in the deeper intima, whereas
HHF-35-positive cells were generally spindle-shaped and tended to be
located in superficial lesions, although there was a considerable
variation from region to region and from lesion to lesion.
|
Examination of serial sections demonstrated that RAM-11-positive MFCs
were the principal cells expressing MMP-12 (Figure 4d)
. The staining
property of MMP-12-positive cells was, however, variable; in
particular, the large vacuolated MFCs often stained weakly or appeared
negative, possibly due to abundance of intracytoplasmic fat vacuoles.
In addition, staining of serial sections and double immunostaining
indicated that a number of SMCs contained immunoreactive MMP-12 in some
areas populated by spindle- or stellate-shaped HHF-35-positive cells
(Figure 5)
. Medial SMCs had no
immunoreactivity with anti-MMP-12 Ab.
|
To examine the functions of MMP-12 at the site of atherosclerotic
lesions in vivo, MMP-12cat (Figure 2)
was manufactured in
the E. coli expression system. After being refolded from the
inclusion body, autolytic cleavage occurred on some portion of the
MMP-12cat, and two sizes of molecules, 20.5 and 19 kd, were obtained
(Figure 6a
, lane 2). Amino-terminal amino
acid sequencing analysis revealed that Met, Ala, and Ser, which were
amino-terminally tagged amino acids, and Phe were removed, and both
types of MMP-12cat had the same amino acid sequence (K-T-M-P-G-R-P).
This result suggested that proteolysis occurred at the 10- to
15-amino-acid upper region of the carboxyl-terminal end of MMP-12cat,
although the purified 19-kd molecule retained elastase activity (Figure 6b)
.
|
, lane 7) and also digested fibronectin
(lane 11), although none of the other collagens were cleaved. MMP-12
also had the ability to activate pro-MMP-2 and pro-MMP-3 in a time- and
concentration-dependent manner (Figure 8)
. In the comparison of Figure 7, a and b
, MMP-12cat's activity on pro-MMP-2 was likely to be much less than
that on pro-MMP-3. The concentration of pro-MMP-3 in the conditioned
medium was 990 ng/ml, as determined by a double-Ab sandwich ELISA
system,32
which indicates that pro-MMP-3 was incubated with
a 3 to 30 times larger molar amount of MMP-12cat in this
experiment.
|
|
Finally, the effect of AcLDL on the production of MMP-12 by the
macrophage cell lines was studied by Northern blot analysis. The
expression of MMP-12 was strengthened by incubation with AcLDL or
GM-CSF in both macrophage-differentiated U937 and THP-1 (Figure 9a)
. The relative amounts of mRNA for
MMP-12, standardized with the amount of mRNA for ß-actin, indicated
that incubation with 35 µg of protein/ml of AcLDL doubled the
expression of MMP-12 in both cell lines (Figure 9b)
. Incubation with
GM-CSF, which is known to increase the transcriptional level of MMP-12
and to enhance the mRNA stability of MMP-12,33
augmented
MMP-12 expression by approximately five times in U937 and approximately
two times in THP-1.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Western blot analysis demonstrated that MMP-12 was also expressed in the atherosclerotic aortas at the protein level. The ability to produce MMP-12 by MFCs, which are the predominant cell population in early atherosclerotic lesions, was also ascertained for MFCs purified directly from atherosclerotic lesions. MMP-12 was detected as a 45-kd active form both in the conditioned medium of MFCs and dissociated cells from the whole aorta. Two possibilities would be raised for the activation process of MMP-12 at the atherosclerotic lesions. First, a serine proteinase, plasmin, which acts as a common activator for most MMPs,3 may play a role in the process. However, MMP-3 was detected as a latent form in our experiment, which is similar to the study by Galis et al12 in which MMP-1 and -3 in the conditioned medium of purified rabbit MFCs kept their latency. Thus, in this situation, MMP-12 may be more sensitive to the proteolytic activity of plasmin than MMP-3. Second, it may be due to the result of self-activation. A number of reports demonstrated that human and mouse MMP-12 was autolytically processed into an activated form.23,24 It is therefore likely that, without exogenous stimuli, MMP-12 has the greater propensity for self-activation than other MMPs.
MMP-2 and -9, which also have elastase activity, were reported to be present in atherosclerotic lesions.7,8,16,34,35 Our study with gelatin zymography confirmed that both MMP-2 and -9 were produced by atherosclerotic arterial cells and were actually present in the conditioned medium (data not shown). It seems likely that the coordinated expression of MMP-2, -9, and -12 is responsible for the elastin degradation in atherosclerotic lesion.
Unlike MMP-2, which has been shown in the intima and the media of aortas with atherosclerotic lesions,7 our immunohistochemical study demonstrated that MMP-12 was restricted to the intima. This suggests that SMCs in the media of the aorta have no ability to produce MMP-12. The reactivity of the rabbit macrophage-specific Ab indicated that the major cell type expressing MMP-12 was macrophage-derived foam cells; this concept was also supported by the result of Western blot analysis of the conditioned medium from purified MFCs. Besides MFCs, small numbers of SMCs that had migrated into intima were also stained with anti-MMP-12 Ab. It is well known that synthetic-state SMCs, which have migrated into the intima, and contractile-state SMCs, which localize in the media, have considerable differences in the molecules they produce, such as cytokines and ECM components.1 Accordingly, MMP-12 might be one of those molecules that can be produced by SMCs in the synthetic state.
The previous study with in situ hybridization indicated that expression of MMP-12 was confined to only a few cells in human carotid atherosclerotic lesions,14 which is inconsistent with our immunohistochemical study finding that MMP-12 was widely expressed in the cells of the rabbit atherosclerotic intima. The reason for the difference is not yet clear, but it may depend on the disparity in the developmental stage of atherosclerosis. Our rabbit hypercholesterolemia model represents an early-middle stage of atherosclerosis, in which MFCs, the principal source of MMP-12, were the major component cells of the intima. Taking these observations together, it is likely that, in atherosclerotic lesions, substantial amounts of MMP-12, which tend to be easily activated, are expressed not in the media but in the intima of the aorta mainly by the MFCs.
Our study of the recombinant MMP-12cat demonstrated that, besides elastin-degrading activity, MMP-12cat cleaved type IV collagen and fibronectin, which are components of the basement membrane.36 MMP-12 is also reported to digest laminin, entactin, and heparan sulfate, all of which constitute basement membranes.26 Therefore, MMP-12 not only reduces the elasticity of the aorta by the digestion of elastin but also may facilitate the influx of inflammatory cells from the blood into the aorta by breaking down basement membranes underlying the endothelium.
In addition to ECM-degrading activity, MMP-12 had the ability to
activate pro-MMP-2 and pro-MMP-3. Pro-MMP-3 was activated by incubation
with a 3 to 30 times larger molar amount of MMP-12cat. Accordingly, in
atherosclerotic lesions, it is likely that MMP-12 functions as an
activator of pro-MMP-3, which in turn activates other pro-MMPs, such as
MMP-1 or -9,37,38
and leads to the degradation of a variety
of ECM proteins, including collagen types I, III, IV, and V and
gelatin. MMP-12 also activated pro-MMP-2. Membrane-type MMPs are
considered to play pivotal roles in activating pro-MMP-2 in
vivo.39
However, the previous demonstration that MMP-1
also activates pro-MMP-240
suggests that activation of
pro-MMP-2 by membrane-type MMPs is not a unique pathway. MMP-12 may
also be implicated in the activation of pro-MMP-2 in the
atherosclerotic intima. In the case of MMP-2, however, not only
pro-MMP-2 but also its activated form decreased with time (Figure 8a)
.
This may be caused by self-cleavage of the molecule in active MMP-2.
The similar phenomenon was reported by Bergmann et al41
that human MMP-2 tended to be degraded by the autolytic processing.
AcLDL, similar to oxidized LDL, is known to be taken up by scavenger receptors and causes generation of foam cells.5 A number of reports have shown that modified LDL induces release of elastase from macrophages.42,43 To our knowledge, our result is the first demonstration that expression of MMP-12 is transcriptionally modulated by AcLDL. Increased expression of MMP-12 may be caused by activation of mitogen-activated protein (MAP) kinase44 and formation of a transcription complex, AP-1,45 the recognition sequence of which, the so-called tumor promoter-recognition element (TRE), exists in the 5'-flanking region of the human MMP-12 gene.46 Expression of MMP-12 by macrophages is enhanced by GM-CSF,34 which is released from endothelial cells by stimulation with modified LDL.47 Hence, in atherosclerotic lesions, modified LDL may be an inducer for MMP-12 expression not only indirectly by causing endothelial cells to secrete GM-CSF but also directly by stimulating macrophages in the course of foam cell formation. Even though additional study is needed, MMP-12 expression from SMC-derived foam cells in the intima may also be related to intracellular lipid accumulation.
In summary, the current study demonstrated the following points. First, diet-induced hypercholesterolemia induced increased expression of MMP-12 by MFCs accumulated in atherosclerotic intimas. Second, MMP-12 had the ability to digest several ECM proteins and to activate other pro-MMPs. Third, MMP-12 expression by MFCs was enhanced by stimulation with modified LDL. These results strongly suggest that increased expression of MMP-12, concomitant with foam cell generation, which triggers the acceleration of ECM breakdown, is a critical step in the initiation and progression of cholesterol-induced atherogenesis. Thus, additional studies will be designed to elucidate the implication of MMP-12 in the pathogenesis of human atherosclerosis.
|
Acknowledgements |
|---|
|
Footnotes |
|---|
Supported in part by a grant from the Japan Society for the Promotion of Sciences (JSPS-RFTF96100202) (to T. Watanabe).
Accepted for publication April 15, 1998.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
1-antitrypsin-elastase complex attacks the elastic lamina of blood vessels: an immunohistochemical study. Histochemistry 1988, 88:443-451[Medline]
fusion protein. Biochem Biophys Res Commun 1996, 228:421-429[Medline]
and plasminogen in rabbit articular cartilage explant culture. J Biochem 1997, 122:49-54This article has been cited by other articles:
 |
|
 |
|
  A Di Sabatino, C L Jackson, K M Pickard, M Buckley, L Rovedatti, N A B Leakey, L Picariello, P Cazzola, G Monteleone, F Tonelli, et al. Transforming growth factor {beta} signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures Gut, June 1, 2009; 58(6): 777 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dwivedi, S. C. Slater, and S. J. George MMP-9 and -12 cause N-cadherin shedding and thereby {beta}-catenin signalling and vascular smooth muscle cell proliferation Cardiovasc Res, January 1, 2009; 81(1): 178 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Dean, J. H. Cox, C. L. Bellac, A. Doucet, A. E. Starr, and C. M. Overall Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx Blood, October 15, 2008; 112(8): 3455 - 3464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bhaskaran, M. O. Palmier, J. L. Lauer-Fields, G. B. Fields, and S. R. Van Doren MMP-12 Catalytic Domain Recognizes Triple Helical Peptide Models of Collagen V with Exosites and High Activity J. Biol. Chem., August 1, 2008; 283(31): 21779 - 21788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xu, F. Xu, and E. Barrett Metalloelastase in lungs and alveolar macrophages is modulated by extracellular substance P in mice Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L162 - L170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yamada, K.-Y. Wang, A. Tanimoto, J. Fan, S. Shimajiri, S. Kitajima, M. Morimoto, M. Tsutsui, T. Watanabe, K. Yasumoto, et al. Matrix Metalloproteinase 12 Accelerates the Initiation of Atherosclerosis and Stimulates the Progression of Fatty Streaks to Fibrous Plaques in Transgenic Rabbits Am. J. Pathol., May 1, 2008; 172(5): 1419 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Shaposhnik, X. Wang, M. Weinstein, B. J. Bennett, and A. J. Lusis Granulocyte Macrophage Colony-Stimulating Factor Regulates Dendritic Cell Content of Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 621 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Thomas, G. B. Sala-Newby, Y. Ismail, J. L. Johnson, G. Pasterkamp, and A. C. Newby Genomics of Foam Cells and Nonfoamy Macrophages From Rabbits Identifies Arginase-I as a Differential Regulator of Nitric Oxide Production Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 571 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. H. Rao, D. T. Meehan, D. Delimont, M. Nakajima, T. Wada, M. A. Gratton, and D. Cosgrove Role for Macrophage Metalloelastase in Glomerular Basement Membrane Damage Associated with Alport Syndrome Am. J. Pathol., July 1, 2006; 169(1): 32 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Liang, E. Liu, Y. Yu, S. Kitajima, T. Koike, Y. Jin, M. Morimoto, K. Hatakeyama, Y. Asada, T. Watanabe, et al. Macrophage Metalloelastase Accelerates the Progression of Atherosclerosis in Transgenic Rabbits Circulation, April 25, 2006; 113(16): 1993 - 2001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kangavari, S. Matetzky, P. K. Shah, J. Yano, K.-Y. Chyu, M. C. Fishbein, and B. Cercek Smoking Increases Inflammation and Metalloproteinase Expression in Human Carotid Atherosclerotic Plaques Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2004; 9(4): 291 - 298. [Abstract] [PDF]
|
|
|
|
|
|
Y. E. Chen MMP-12, An Old Enzyme Plays a New Role in the Pathogenesis of Rheumatoid Arthritis? Am. J. Pathol., October 1, 2004; 165(4): 1069 - 1070. [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, J. Liang, T. Koike, H. Sun, T. Ichikawa, S. Kitajima, M. Morimoto, H. Shikama, T. Watanabe, Y. Sasaguri, et al. Overexpression of Human Matrix Metalloproteinase-12 Enhances the Development of Inflammatory Arthritis in Transgenic Rabbits Am. J. Pathol., October 1, 2004; 165(4): 1375 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Haug, C. Lenz, F. Diaz, and M. G. Bachem Oxidized Low-Density Lipoproteins Stimulate Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Release by Coronary Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1823 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Whatling, H. Bjork, S. Gredmark, A. Hamsten, and P. Eriksson Effect of macrophage differentiation and exposure to mildly oxidized LDL on the proteolytic repertoire of THP-1 monocytes J. Lipid Res., September 1, 2004; 45(9): 1768 - 1776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. Larsen and V. W. Yong The Expression of Matrix Metalloproteinase-12 by Oligodendrocytes Regulates Their Maturation and Morphological Differentiation J. Neurosci., September 1, 2004; 24(35): 7597 - 7603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yasuda, Z. Li, D. Greenbaum, M. Bogyo, E. Weber, and D. Bromme Cathepsin V, a Novel and Potent Elastolytic Activity Expressed in Activated Macrophages J. Biol. Chem., August 27, 2004; 279(35): 36761 - 36770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Castrillo, S. B. Joseph, C. Marathe, D. J. Mangelsdorf, and P. Tontonoz Liver X Receptor-dependent Repression of Matrix Metalloproteinase-9 Expression in Macrophages J. Biol. Chem., March 14, 2003; 278(12): 10443 - 10449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Manning, L. A. Cassis, and A. Daugherty Differential Effects of Doxycycline, a Broad-Spectrum Matrix Metalloproteinase Inhibitor, on Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 483 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wronski, E. Seeliger, P. B. Persson, A. Harnath, and B. Flemming Influence of baroreflex on volume elasticity of heart and aorta in the rabbit Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R842 - R849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Vaillant, M. G. Chiaramonte, A. W. Cheever, P. D. Soloway, and T. A. Wynn Regulation of Hepatic Fibrosis and Extracellular Matrix Genes by the Th Response: New Insight into the Role of Tissue Inhibitors of Matrix Metalloproteinases J. Immunol., December 15, 2001; 167(12): 7017 - 7026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Warner, C. S. Lewis, L. Beltran, E. M. Younkin, J. Varani, and K. J. Johnson The Role of Metalloelastase in Immune Complex-Induced Acute Lung Injury Am. J. Pathol., June 1, 2001; 158(6): 2139 - 2144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Koolwijk, N. Sidenius, E. Peters, C. F. M. Sier, R. Hanemaaijer, F. Blasi, and V. W. M. van Hinsbergh Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices Blood, May 15, 2001; 97(10): 3123 - 3131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Saito, N. Yamaji, K. Yasunaga, T. Saito, S.-i. Matsumoto, M. Katoh, S. Kobayashi, and Y. Masuho The Fibronectin Extra Domain A Activates Matrix Metalloproteinase Gene Expression by an Interleukin-1-dependent Mechanism J. Biol. Chem., October 22, 1999; 274(43): 30756 - 30763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lindstedt, J. Saarinen, N. Kalkkinen, H. Welgus, and P. T. Kovanen Matrix Metalloproteinases-3, -7, and -12, but Not -9, Reduce High Density Lipoprotein-induced Cholesterol Efflux from Human Macrophage Foam Cells by Truncation of the Carboxyl Terminus of Apolipoprotein A-I. PARALLEL LOSSES OF PRE-beta PARTICLES AND THE HIGH AFFINITY COMPONENT OF EFFLUX J. Biol. Chem., August 6, 1999; 274(32): 22627 - 22634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Feinberg, M. K. Jain, F. Werner, N. E. S. Sibinga, P. Wiesel, H. Wang, J. N. Topper, M. A. Perrella, and M.-E. Lee Transforming Growth Factor-beta 1 Inhibits Cytokine-mediated Induction of Human Metalloelastase in Macrophages J. Biol. Chem., August 11, 2000; 275(33): 25766 - 25773. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-elastin containing 10%
SDS-PAGE gel. Elastin zymography
